Test Bank -Ruppel's Manual of Pulmonary Function Testing, 12th Edition( Carl Mottram, 2025), All Chapters ||Latest Edition

Test Bank for Ruppel’s Manual of Pulmonary Function Testing
ii ii ii ii ii ii ii ii




ii 12th Edition, By Mottram
ii ii ii




Chapter 1 - 13 Updated
ii ii ii ii ii

,Chapter 1: Indications for Pulmonary Function Testing Test Bank
i i i i i i i ii




MULTIPLE iiCHOICE

1. Who iifirst iipopularized iispirometry iifor iithe iievaluation iiof iipulmonary iifunction?
a. August iiand iiMarie iiKrogh
b. Alvan iiBarach
c. John iiSeveringhaus
d. John iiHutchinson

ANS: iiD
Hutchinson iipopularized iithe iiconcept iiof iiusing iiVC iito iiassess iilung iifunction, iiand iithe iinames
iihe iigave iito iiseveral iiother iilung iicompartments iiare iistill iiused iitoday.




DIF: 1 REF: p. ii2 OBJ: None i i MSC: iiNBRC: iiNone

2. Which iiof iithe iifollowing iiare iiindications iifor iiperforming iispirometry?
1. Assess iithe iirisk iiof iilung iiresection.
2. Determine iithe iiresponse iito iibronchodilator iitherapy.
3. Assess iithe iiseverity iiof iirestrictive iilung iidisease.
4. Quantify iithe iiextent iiof iiCOPD.
a. 1 i i and i i 4
b. 2 i i and i i 3
c. 1 ii, ii2, iiand i i 4
d. 2 ii, ii3, iiand i i 4

ANS: iiC
Spirometry iicannot iiassess iiseverity iiof iirestriction; iifor iithat iiyou iineed iito iimeasure iilung
iivolumes ii( iisee iiBox ii1-2, iiChapter i i 1).




DIF: 1 REF: p. ii7 OBJ: EL-2 MSC: iiNBRC: iiNone

,3. The iimain iiindication iifor iithe iimeasurement iiof iilung iivolumes iiis iito iido iiwhich iiof iithe
iifollowing?


a. Diagnose iior iiassess iithe iiseverity iiof iirestriction.
b. Evaluate iithe iiseverity iiof iipulmonary iihypertension.
c. Determine iithe iilevel iiof iicardiopulmonary iifitness.
d. Assess iithe iirisk iiof iiabdominal iisurgical iiprocedures.

ANS: iiA
The iimost iicommon iireason iifor iimeasuring iilung iivolumes iiis iito iiidentify iirestrictive iilung

disease. iiDIF:
ii 1 REF: p. ii35 OBJ: EL-2 MSC: iiNBRC: iiNone

4. DLCO iimeasurements iimay iibe iiindicated iito iievaluate iipulmonary iiinvolvement iiin iiwhich iiof
iithe iifollowing iisystemic iidiseases?


a. Asthma
b. Sarcoidosis
c. Exertional iihypoxemia

, Stuvia.com ii- iThe iiMarketplace iito iiBuy iiand iiSell iiyour iiStudy
iiMaterial



d. Guillain-Barré iisyndrome

ANS: iiB
Sarcoidosis iiis iithe iionly iisystemic iidisease iilisted iithat iiaffects iigas

exchange. iiDIF: ii1 iiREF: iip. ii9 ii| iip. ii19 ii| iip. ii21 ii| iip. ii35 iiOBJ: iiEL-2 iiMSC:
ii




ii NBRC: iiNone

5. Blood iigas iianalysis iiis iiused iiwith iipatients iiwith iiCOPD iito iido iiwhich iiof
iithe iifollowing?


a. Monitor iiairway iiresponsiveness.
b. Determine iilevel iiof iicardiopulmonary iifitness.
c. Detect iipulmonary iihypertension.
d. Assess iineed iifor iisupplementary iiO2.

ANS: iiD
Blood iigas iianalysis iiis iimost iicommonly iiused iito iidetermine iithe iineed iifor iisupplemental
iioxygen iiand iito iimanage iipatients iiwho iirequire iiventilatory iisupport.




DIF: 2 REF: p. ii15 OBJ: EL-1
iiMSC: iiNBRC: iiCPFT ii2A-2




6. Which iiof iithe iifollowing iicause iiemphysema?
1. 1- iiAntitrypsin iideficiency
2. Exposure iito iienvironmental iipollutants
3. Radiation iitherapy
4. Cigarette iismoking
a. 1 i i and i i 2
b. 3 i i and i i 4
c. 1 ii, ii2, iiand i i 4
d. 2 ii, ii3, iiand i i 4

ANS: iiC
Emphysema iiis iicaused iiprimarily iiby iicigarette iismoking. iiSome iiemphysema iiis iicaused iiby iithe
iiabsence iiof iia iiprotective iienzyme. iiChronic iiexposure iito iienvironmental iipollutants iican iialso

iicontribute iito iithe iidevelopment iiof iiemphysema.




DIF: 1 REF: p. ii11 OBJ: EL-3 ii| iAL-2 MSC: iiNBRC: iiNone

7. An iiadult iipatient iicomplains iiof iichest iitightness iiand iicough iiwhenever iihe iijogs iiin iicold
iiweather. iiThese iisymptoms iiare iiconsistent iiwith iiwhich iiof iithe iifollowing?


a. Cystic iifibrosis
b. Asthma
c. Pulmonary iihypertension
d. Idiopathic iipulmonary iifibrosis


|